OEL
职业接触限值数据库
腺苷
Adenosine
腺素苷
,
腺甙
,
9-beta-D-呋喃核糖基腺嘌呤
,
腺嘌呤核苷, (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, Adenosin, β-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, 9β-D-ribofuranosyl-9H-Purin-6-amine, Adesine, 1-(6-amino-9H-purin-9-yl)-1-deoxy-β-D-Ribofuranose, 6-Amino-9-b-D-ribofuranosyl-9H-purine, Adenocor, Sandesin, (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydro-3,4-furandiol, 9-β-δ-Ribofuranosidoadenine, (-)-adenosine, 9-β-δ-Ribofuranosyl-9H-purin-6-amine, (–)-adenosine, 9-b-D-Ribofuranosidoadenine, D-Adenosine, MFCD00005752, Adenosine, Adenine-9-beta-D-ribofuranoside, Adrekar, 9-β-D-Ribofuranosyladenine, 9-beta-D-Ribofuranosyladenine, 9-b-D-Ribofuranosyl-9H-purin-6-amine, Boniton, Adenine riboside, Adenoscan, adenine-9β-D-Ribofuranoside, Adenocard, EINECS 200-389-9, 9-β-D-Arabinofuranosyladenine, Myocol
CAS号: 58-61-7
SMILES: C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
EC号: 200-389-9
免责声明 Disclaimer
1. CIRS努力保证内容的准确性并及时更新。但是，CIRS不对信息的质量、准确性、完整性或可靠性负责。
2. 在任何时候，CIRS不对因用户使用本数据库的信息导致的任何声明、损害或者损失负责以及承担责任。
3. CIRS保留在没有事先通知的情况下进行修改、修正、增加或者移除部分信息的权利。
